BridgeMD
Tests treatment safety and results for Parkinson Disease
Official title Efficacy of Acupuncture for the Treatment of Parkinson's Disease Related Constipation
ClinicalTrials.gov ID: NCT06390761
What this study is testing
- What it's testing
- The purpose of the study is to evaluate the efficacy of acupuncture in treating Parkinson's disease related constipation (PDC). In the randomized controlled clinical trial study, patients meeting the criteria for inclusion will be randomly enrolled and divided into two groups in a 1:1 ratio: the acupuncture group and the sham acupuncture group.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 35 to 80
You may be able to join if
- A diagnosis of PD (according to the Movement Disorder Society's revised clinical diagnostic criteria for Parkinson's disease in 2015) and functional...
- Age between 35 and 80 years;
- Hoehn-Yahr grade ≤ 3;
- No medications taken within 2 weeks that may affect gastrointestinal function (such as prucalopride and probiotics);
- No anticipation in other clinical trials within 1 month;
You likely can't join if
- Organic lesions of the digestive system (such as intestinal adhesions, obstructions, tumors, or malformations in the gastrointestinal tract);
- A history of abdominal or anorectal surgery that may affect intestinal transit, systemic diseases that may affect the dynamics of the digestive tract...
- Serious life-threatening diseases (such as severe cardiovascular diseases and malignant tumors);
- Skin lesions that were inappropriate for needling, the viscose allergy that prevented acupuncture device attachment;
- Pregnant or lactating women.
See the full eligibility criteria
- A diagnosis of PD (according to the Movement Disorder Society's revised clinical diagnostic criteria for Parkinson's disease in 2015) and functional constipation (according to the Rome IV diagnostic criteria) ;
- Age between 35 and 80 years;
- Hoehn-Yahr grade ≤ 3;
- No medications taken within 2 weeks that may affect gastrointestinal function (such as prucalopride and probiotics);
- No anticipation in other clinical trials within 1 month;
- Voluntary engagement in this study, ability to sign the informed consent, and cooperation in the completion of the bowel diary and scale filling.
- Organic lesions of the digestive system (such as intestinal adhesions, obstructions, tumors, or malformations in the gastrointestinal tract);
- A history of abdominal or anorectal surgery that may affect intestinal transit, systemic diseases that may affect the dynamics of the digestive tract (such as diabetes and hyperthyroidism);
- Serious life-threatening diseases (such as severe cardiovascular diseases and malignant tumors);
- Skin lesions that were inappropriate for needling, the viscose allergy that prevented acupuncture device attachment;
- Pregnant or lactating women.
The study team makes the final eligibility decision.
Where it's taking place
- Xi'an, Shaanxi, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 35 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Xi'an, Shaanxi, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.